Log In
Print
BCIQ
Print
Print this Print this
 

MM-141

  Manage Alerts
Collapse Summary General Information
Company Merrimack Pharmaceuticals Inc.
DescriptionTetravalent bispecific antibody targeting insulin-like growth factor 1 (IGF-1) receptor (IGF1R; CD221) and epidermal growth factor receptor 3 (EGFR3; HER3; ErbB3)
Molecular Target Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3) ; Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today